 IRVINE, CA ACCESSWIRE March 10, 2021 Odyssey Group International, Inc. OTCQB:ODYY the Company or Odyssey, a technology and asset acquisition company focused on developing unique, life-saving medical products, is pleased to announce that Dr. Jake VanLandingham, Odysseys Vice President of Drug Development and the lead scientist developing PRV-002 will be joining Brett Favre to discuss the impact of concussions and the importance of this novel concussion treatment on NewsNation Nows The Donlon Report. The segment is expected to air at 7:30PM Eastern Time on March 10, 2021. 